Big Gain For Evommune Inc.

Tue, Feb 10, 2026 at 07:18 PM

Evommune Inc. (EVMN:NYSE) rocketted at $29.03, a gain of 70.9%. On Tue, Feb 10, 2026, EVMN:NYSE hit a New 2-Week High of $29.03. The stock appeared on our News Catalysts scanner on Tue, Feb 10, 2026 at 09:23 AM in the 'BIOTECH' category. From Wed, Jan 28, 2026, the stock recorded 55.56% Up Days and 40.00% Green Days

About Evommune Inc. (EVMN:NYSE)

Evommune is a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases, with initial clinical development programs focusing on...

Top 10 Gainers:

Quince Therapeutics, Inc. (QNCX:NASDAQ), 305.92%
Jiuzi Holdings, Inc. (JZXN:NASDAQ), 89.71%
Evommune Inc. (EVMN:NYSE), 70.87%
TuHURA Biosciences, Inc. (HURA:NASDAQ), 60.47%
Founder Group Limited (FGL:NASDAQ), 55.96%
Nektar Therapeutics (NKTR:NASDAQ), 51.07%
ZW Data Action Technologies Inc. (CNET:NASDAQ), 49.99%
SRx Health Solutions Inc. (SRXH:NYSEMKT), 45.55%
BiomX Inc. (PHGE:NYSEMKT), 44.37%
European Wax Center, Inc. (EWCZ:NASDAQ), 43%